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Fertility transition in Sub-Saharan Africa has been slow: 
The total fertility rate for the region was 6.8 in the late 
1970s and is now a little below 5.0.1 In addition, modern 
contraceptive use is low: Only 25% of married women in 
Sub-Saharan Africa were using a modern method in 2015, 
compared with 58% globally. Contraceptive use is increas-
ing, however, largely because of rising uptake of the inject-
able. In 2015, the method accounted for 45% of all modern 
method use in Sub-Saharan Africa, and the pill accounted 
for an additional 22%.2 The injectable is highly effective 
and can be delivered by lower-level paramedical staff, but 
these advantages are offset by low adherence, high discon-
tinuation and low switching to alternative methods after 
discontinuation.3–5
Improving women’s access to a wider range of methods—
including long-acting reversible methods (LARCs), defined 
here as the IUD and the implant—will give women more 
choice and should reduce unmet need, which is increas-
ingly the result of discontinuation of short-acting methods.6 
LARCs are typically used for longer durations than the 
injectable or the pill,3 and thus are particularly appropri-
ate for the growing number of women who want to cease 
childbearing altogether.7 Women may use LARCs longer 
because those who choose them are more committed to 
long-term avoidance of pregnancy; another reason may be 
that LARC discontinuation requires a firm decision and a 
visit to a health facility, where health staff may encourage 
clients to persist with the method. According to a random-
ized, controlled trial in the United States, characteristics of 
the method rather than of the user account for the differ-
ence in discontinuation between LARCs and other revers-
ible methods.8
Major initiatives to increase access to LARCs in Africa—
funded by bilateral donors and foundations, and imple-
mented with input from such international nongovern-
mental organizations as Marie Stopes International (MSI) 
and Population Services International (PSI)—have been 
launched in the past decade. Some of these projects were 
designed for the general population, whereas others were 
focused on women who had recently given birth or had an 
abortion, those living with HIV, those affected by conflict 
and the young. Many placed equal emphasis on the IUD 
and the implant, but some were dedicated to one or the 
other.9
The objective of this article is to review key components 
of LARC uptake in Sub-Saharan Africa with the aim of 
guiding policies and programs. We assess trends in access 
to the IUD and implant, including method knowledge and 
availability at facilities; examine trends in use, source of 
supply, discontinuation and characteristics of users; and 
discuss the prospects for expanding method choice by 
increasing the availability of LARCs in national programs 
and the policy implications of our results.
METHODS
This analysis is based on data from Demographic and 
Health Surveys (DHSs), health facility surveys and tele-
phone interviews with key international family planning 
stakeholders, as well as findings from recently published 
literature reviews on enablers and barriers to IUD uptake 
in low- and middle-income countries.9,10 Unless otherwise 
stated, our IUD analyses refer to copper devices and our 
implant analyses refer to the generic method (including 
levonorgestrel- and etonogestrel-based implants) rather 
than to specific brands.
Demographic and Health Surveys
To examine time trends in women’s knowledge and use 
of the IUD and implant, we used DHS data from the 22 
Sub-Saharan African countries that had had one survey 
conducted between 1996 and 2000, and another between 
2010 and 2016 (Appendix Table 1). DHS surveys are cross-
sectional and nationally representative, and are based on 
multilevel cluster sampling of households. Women aged 
15–49 years are interviewed about a range of reproductive 
and maternal issues.
Method awareness is the first essential component of 
access and demand for specific contraceptives. We ana-
lyzed women’s responses to questions on whether they 
had ever heard of the IUD and the implant as family plan-
ning methods after the methods were described to them in 
detail. Also, we used women’s reports of the method they 
were using at the time of the survey to assess time trends 
in IUD and implant use.
In addition, in countries where at least 50 women 
reported current IUD or implant use in the survey in the 
2010–2016 period (Benin, Kenya, Lesotho, Nigeria, Rwanda, 
Sierra Leone, Togo and Zambia), we examined users’ 
reported source of their method. We classified sources into 
three categories: public sector, private sector (including 
commercial, nongovernmental and faith-based providers) 
and other (including uncertain and missing responses).11 
Results should be interpreted with caution because private-
public collaboration obfuscates supply source.12
Furthermore, differences in supply source may reflect 
differences in the characteristics of women who choose a 
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specific method. Therefore, we examined the social and 
demographic characteristics of IUD and implant users in 
countries with at least 100 current users of each method 
(Kenya, Nigeria, Rwanda and Zambia).
Analyses were conducted using Stata SE15 and adjusted 
for survey design (clustering, weights and stratification). 
The DHS program receives government permission to 
field a survey, and participants provide informed consent 
and are assured of confidentiality. This study was approved 
by the Research Ethics Committee of the London School 
of Hygiene and Tropical Medicine.
We also used aggregate data reported elsewhere3 to 
analyze antecedents to IUD and implant uptake. We 
relied on a detailed analysis of DHS contraceptive calen-
dar data from surveys conducted between 2010 and 2014 
that show the proportions of IUD and implant adopters 
who started use in the month following birth, postpar-
tum abstinence, lactational amenorrhea or extended 
breast-feeding; switched from another method (switch-
ing was given preference if women reported it together 
with postpartum abstinence); or were using no method 
immediately prior to adoption. Furthermore, we used 
indicators showing 12-month discontinuation among 
IUD users (in four countries) and implant users (in 13 
countries) from surveys in Sub-Saharan Africa for the 
same time period (2010–2014), as available on the DHS 
Statcompiler website.
Health Facility Surveys
Awareness of a method is of little consequence for 
potential adoption without knowledge of and access 
to a source from which that method can be obtained. 
Unfortunately, such information is not collected in 
DHS or similar surveys. However, since 2010, ICF has 
published four Service Provision Assessments (SPAs) 
for African countries as part of the DHS program,13–16 
and FP2020 has published information sheets with key 
results from five national Performance Monitoring and 
Accountability (PMA) facility surveys.17–21 Eight African 
countries were captured in these nine surveys; Kenya 
had both surveys, and we used the PMA, which is the 
most recent. Both SPAs and PMAs employ teams who 
visit selected facilities and, through interviews and 
observation, collect a range of information, including 
the availability of LARCs and other methods on the 
day of the visit. Samples are designed to be nation-
ally representative and include public, private, non-
governmental and faith-based facilities; sample sizes 
are typically  200–500 facilities. Data on both IUD 
and implant stockouts in 17 African countries were 
available from facility surveys conducted in 2015 by 
UNFPA-Supplies.22
Key Stakeholder Interviews
In April through June 2016, one of the coauthors 
conducted semistructured telephone interviews with 
staff from organizations known to be active in pro-
viding support to national programs to offer the 
IUD—the U.S. Agency for International Development, 
UK Department for International Development, MSI, 
PSI, Pathfinder International, International Planned 
Parenthood Federation, DKT International and FHI360. 
The purpose of the interviews was to identify the scale 
of IUD-related activities and the main awareness- raising 
and delivery mechanisms, and to obtain a general evalu-
ation of difficulties and obstacles encountered. The most 
senior representative of each organization was contacted 
initially and was asked to participate or identify another 
appropriate senior staff member. Interviewees were asked 
to represent the experience of their organization; inter-
views lasted 60–90 minutes. We summarize the most 
commonly cited factors relevant to Sub-Saharan Africa.
RESULTS
Knowledge
The 22 countries with a survey in the specified time peri-
ods include the two most populous African nations (Nigeria 
and Ethiopia) and provide a good representation of both 
Eastern and Western Africa. Knowledge of the IUD among 
all married women varied widely by country: In the second 
survey period, the proportion who were aware of the IUD 
ranged from fewer than 20% in Chad and Niger to at least 
80% in Kenya, Malawi, Rwanda, Tanzania and Zimbabwe 
(Figure 1). In 12 of the 22 countries, IUD awareness rose 
between the two periods, with particularly sharp increases 
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FIGURE 1. Percentage of married women aged 15–49 with knowledge of the IUD, by 
country and DHS survey period
This content downloaded from 194.80.229.244 on Fri, 13 Jul 2018 12:52:07 UTC
All use subject to http://about.jstor.org/terms
Volume 43, Number 4, December 2017 185
in Rwanda and Tanzania; awareness fell in six countries and 
remained unchanged in four. On average, IUD awareness 
rose modestly, from 44% to 52% (not shown).
In contrast, knowledge of the implant increased among 
married women in every country studied (Figure 2). In 
the first survey period, implant awareness was higher than 
50% in only two countries; however, by the second period, 
that number had risen to 16, and awareness was higher 
than 80% in 12 countries. On average, implant awareness 
increased from 19% to 66% (not shown).
Availability
According to data from eight facility surveys, the avail-
ability of both the IUD and the implant at facilities that 
offer any contraceptive method was low in Ghana, Senegal 
and Uganda, and high in Burkina Faso and Tanzania 
(Figure 3). In Ethiopia, Kenya and Malawi, the availabil-
ity of the implant was much higher than that of the IUD. 
Although it is dangerous to generalize from such a small 
number of surveys, it appears that the implant tends to 
be more available than the IUD. In addition, data from 
UNFPA-Supplies surveys conducted in 17 Sub-Saharan 
African countries in 2015 show that 0–66% of facilities did 
not have the IUD in stock when surveyed, and 0–47% did 
not have the implant in stock (not shown); the medians 
were 26% and 19%, respectively. These data support the 
impression that shortages are more common for the IUD 
than for the implant.
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FIGURE 2. Percentage of married women aged 15–49 with knowledge of the implant, 
by country and DHS survey period
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FIGURE 3. Among health facilities offering any contraceptive method, percentage that had LARCs in stock on the day of survey 
visit, by country
Notes: Data are from the following Performance Monitoring and Accountability (PMA) facility surveys and Service Provision Assessments (SPAs): Burkina Faso, 2016 
PMA; Ethiopia, 2016 PMA; Ghana, 2015 PMA; Kenya, 2015 PMA; Malawi, 2013–2014 SPA; Senegal, 2014 SPA; Uganda, 2015 PMA; and Tanzania, 2014–2015 SPA.
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Lack of contraceptive commodities can arise not only 
from delays in the supply chain, but also from actual or 
perceived low demand for a method leading to facilities 
not ordering it, and from a lack of staff trained to deliver it. 
In 23 African countries, some facilities—particularly lower 
level ones—were not offering LARCs because of lack of 
trained staff; detailed estimates for the implant, but not for 
the IUD, are available.23
Use
Between the two survey periods, current modern method 
use among married women increased in all 22 study coun-
tries. In the first period, prevalence was less than 10% in 
14 countries, and the mean for all countries was 11%. By 
the second period, use was lower than 10% in only four 
countries (Benin, Chad, Guinea and Mali), and the mean 
had risen to 24%, in part because of steep increases in 
most of the East African countries.
Figures 4 and 5 chart the changing contributions of 
the IUD and the implant, respectively, to the 22 coun-
tries’ modern method mix between the two survey peri-
ods. Although interpretation must be cautious because of 
the very low levels of overall modern method use in the 
earlier period, there seems to be a clear contrast between 
the figures. The contribution of the IUD decreased or 
remained static in all countries. In the second period, 
the IUD made up more than 5% of the method mix only 
in Kenya, where overall modern method use is high, 
and Benin, where modern method use is low. By con-
trast, the implant’s contribution increased in all coun-
tries. That trend is to be expected because, in the late 
1990s, the implant was just being introduced into family 
planning services, and use of the method was close to 
zero in many countries. But the implant’s contribution 
to the overall method mix in the second survey period 
is remarkable—exceeding 10% in 15 countries and 20% 
in six countries. The IUD’s contribution in the second 
period surpassed the implant’s in only three countries—
Gabon, Guinea and Mozambique, where use of both 
methods was low.
When overall modern method use rises fast, a decreased 
method mix contribution of the IUD does not necessar-
ily mean a decrease in use of the method among all mar-
ried women. However, examination of method-specific 
prevalence among all currently married women shows 
that IUD use remained below 1% in both survey periods 
in 18 of the 22 countries, and that more countries experi-
enced small declines between surveys than small increases 
(not shown). In comparison, implant use in the second 
period exceeded 5% in six countries and was 3–5% in 
another four.
Method Source
In seven of the eight countries where at least 50 women 
reported current IUD or implant use in a 2010–2016 sur-
vey, the public sector was the dominant source of both 
methods (serving >60% of users); Lesotho was the outlier, 
with 58% of IUD users receiving their method from the 
private sector. In all countries except Sierra Leone, how-
ever, implant users were more reliant on the public sector 
than IUD users; this was most pronounced in Lesotho, 
Kenya and Rwanda. Very few IUD or implant users (<3%) 
received their method from other sources, except in Benin 
and Rwanda.
User Characteristics
Table 1 shows the social and demographic characteristics 
of IUD and implant users in the four Sub-Saharan African 
countries with at least 100 current users of each method 
in the most recent DHS survey. In Kenya and Zambia, 
IUD users were more educated, older and wealthier than 
implant users. In Rwanda, IUD users were more educated 
and wealthier than implant users, and also were more 
likely to live in an urban area. Of these four characteristics, 
only age differed significantly by method in Nigeria—with 
IUD users again tending to be older than implant users. 
Number of living children did not differ between IUD 
users and implant users in any of the four countries.
The percentage of IUD users who wanted to cease child-
bearing ranged from 61% in Rwanda to 70% in Nigeria; 
the corresponding range among implant users was 40% 
(in Nigeria) to 57% (in Rwanda). The difference in desire 
for more children between method users was statistically 
significant in Kenya and Nigeria.
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FIGURE 4. Among married women aged 15–49 currently using a modern method, 
percentage relying on the IUD, by country and DHS survey period
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Initiation and Discontinuation
Using aggregate data, we examined antecedents to LARC 
use and probability of discontinuation (not shown). In 
most of the 12 Sub-Saharan African surveys with a sam-
ple of more than 100 episodes of method initiation,* the 
majority of IUD and implant users had been using no 
method immediately prior to adoption; the main excep-
tions were implant users in Zimbabwe (42% switched 
from another modern method) and IUD users in Zambia 
(48% started using following the immediate or extended 
postpartum period). A direct comparison of the propor-
tions of IUD and implant users who initiated use fol-
lowing the immediate or extended postpartum period 
could be made for seven countries: For the IUD, the 
proportions ranged from 12% to 23%, with the excep-
tion of Zambia (48%); for the implant, the proportions 
ranged from 26% to 49%, with the exception of Rwanda 
(9%). A tentative conclusion is that, following childbirth, 
women in Sub-Saharan Africa are more likely to adopt the 
implant than the IUD. This contrasts with pooled find-
ings in other low- and middle-income regions that show 
that postpartum women are more likely to adopt the IUD 
than the implant.3
In addition, we examined implant discontinuation 
data among all women, which were available on the DHS 
Statcompiler website for 13 African countries. In 10 of 
those countries, 12-month, all-cause discontinuation was 
less than 10%; the exceptions were Benin (35%), Mali 
(18%) and Uganda (12%). Similar IUD discontinuation 
data were available for only four countries: Kenya (6%), 
Nigeria (9%), Zambia (12%) and Burundi (15%). Direct 
comparisons can be made for Kenya and Zambia, where 
rates of implant discontinuation were 8% and 4%, respec-
tively. Moreover, we can compare discontinuation of the 
two methods among all married users in Nigeria (10% for 
the IUD and 11% for the implant).3 In conclusion, discon-
tinuation is low for both methods, and no clear-cut differ-
ence can be established in Sub-Saharan Africa on the basis 
of these data; however, a report based on 22 DHS surveys 
drawn from all regions shows appreciably lower discon-
tinuation of the implant than of the IUD.3
Apart from DHS data, evidence that permits compari-
son of IUD and implant discontinuation in Sub-Saharan 
Africa is very scarce. Discontinuation data are available 
from a follow-up survey of 3,278 IUD acceptors and 995 
implant acceptors—all recipients of MSI mobile services—
in five countries, including Ethiopia and Sierra Leone.24 
Of those, Sierra Leone was the only one for which dis-
continuation for the two methods could be compared: At 
eight or more months, discontinuation was 16% for the 
IUD and 6% for the implant. Side effects were reported 
by about 40% of IUD and implant users in Sierra Leone, 
and by a similar proportion of implant users in Ethiopia. 
*Countries with 100 episodes of IUD initiation included Burundi, Nigeria 
and Zambia; countries with 100 episodes of implant initiation included 
Burkina Faso, Liberia, Nigeria, Senegal, Sierra Leone, Rwanda, Uganda, 
Zambia and Zimbabwe.
Of those, 30–40% had sought medical help, and difficulty 
in finding such help was reported by 27% in Ethiopia 
and by 20% in Sierra Leone. These findings demonstrate 
that low discontinuation does not imply the absence of 
side effects deemed serious enough to warrant a health 
consultation.
A key issue for family planning services in Sub-Saharan 
Africa is whether the hormonal IUD is superior to the cop-
per IUD and the implant in terms of satisfaction and use-
continuation. Efforts to increase availability of the device 
in Africa have been advocated, and reductions in price 
have made the suggestion more feasible, although cost 
remains a concern for donors.25,26 Regrettably, evidence for 
Sub-Saharan African countries is absent, largely because 
use of the hormonal IUD is uncommon, and few surveys 
distinguish between IUD types. Evidence from more- 
developed countries suggests that the hormonal IUD is 
similar to the copper IUD in terms of continuation and 
satisfaction.27–30 In the only study we could find in a devel-
oping country (Kenya) that compares the hormonal IUD 
and the implant, 12-month continuation was almost iden-
tical (about 90%);31 at six months, satisfaction was higher 
among hormonal IUD users than among implant users, 
but the gap narrowed by 12 months. Although menstrual 
disruption is a common source of dissatisfaction in Africa, 
78% of hormonal IUD users considered their bleeding 
pattern highly acceptable, compared with 66% of implant 
users. Efforts are currently under way to understand the 
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profile of hormonal IUD users and the impact of adding 
the device to the method mix in selected Sub-Saharan 
African countries.32
Key Stakeholder Interviews
The main reasons identified by stakeholders for low IUD 
use in Sub-Saharan Africa were related to the interaction 
between women and providers. First, providers might not 
present the IUD as an option because they hold misconcep-
tions about the method (e.g., that the IUD moves around 
in the body and causes infection); because it requires 
more time to provide than other methods; or because they 
believe that other methods, including the implant, might 
be more suitable due to higher perceived effectiveness and 
the fact that other methods do not require insertion deep 
inside the body. The fact that an implant is considerably 
more difficult to remove than an IUD is not explained to 
women. Second, women might not feel comfortable having 
an IUD inserted by a male provider. And third, many facili-
ties lack the space to provide women with privacy during 
the insertion.
In addition, stakeholders often mentioned that some 
women believe the IUD is less effective than other mod-
ern methods, such as the implant. This was attributed to 
greater efforts by donors, health ministries and provid-
ers to communicate information about the implant than 
about the IUD. Side effects—in particular heavy menstrual 
 bleeding—act as a further deterrent. Interviewees reported 
that women consider the implant less intrusive than the 
IUD, and that the implant—being a relatively new method—
has been the subject of fewer misconceptions and concerns.
Several informants reported feeling that the implant 
is more acceptable to women than the IUD, and that the 
method is favored by some agencies for this reason. They 
also mentioned the lack of national-level support for pro-
viding the IUD, which is reflected in supply chain issues 
and the restrictions in some countries on nurses and mid-
wives inserting the IUD, and results in lack of demand and 
consequent loss of provider skills and confidence (particu-
larly in rural areas with low client volumes).
To address low IUD utilization, interviewees sug-
gested information and education activities to counter 
TABLE 1. Social and demographic characteristics of IUD and implant users aged 15–49 in four Sub-Saharan African countries for which there were at 
least 100 current users of each method in the most recent DHS survey
Characteristic Kenya, 2014 Nigeria, 2013 Rwanda, 2014–2015 Zambia, 2013–2014
IUD
(n=614)
Implant
(n=1,969)
p IUD
(n=304)
Implant
(n=101)
p IUD
(n=105)
Implant
(n=645)
p IUD
(n=111)
Implant
(n=667)
p
Education
None 0.9 3.1
<.001
5.8 10.5
.364
6.5 14.6
<.001
2.0 5.3
.050
Primary 43.1 55.3 30.0 18.9 53.5 68.7 48.3 49.8
Secondary 30.4 28.8 40.2 43.2 20.2 13.3 40.7 41.3
>secondary 25.6 12.8 24.0 27.4 19.8 3.4 9.0 3.6
Age-group
15–19 0.4 3.2
<.001
0.9 0.0
<.001
0.0 2.0
.359
0.7 5.5
.021
20–24 7.1 18.7 2.9 7.6 4.7 9.3 6.3 17.7
25–29 23.0 30.4 10.4 15.3 17.6 22.8 22.8 22.1
30–34 22.7 22.1 20.1 40.0 30.4 27.1 24.6 21.5
35–39 19.4 15.7 23.3 22.5 24.2 18.9 23.2 18.9
40–49 27.4 9.9 42.4 14.6 23.1 19.9 22.4 14.3
Mean 34.2 30.1 37.5 32.9 34.6 32.8 33.8 30.9
Residence
Urban 54.3 48.2
.109
70.8 74.9
.612
50.1 24.4
<.001
68.0 56.9
.059
Rural 45.7 51.8 29.2 25.1 49.9 75.6 32.0 43.1
Wealth quintile
Poorest 2.6 9.8
<.001
0.2 0.6
.748
6.5 17.4
<.001
5.0 10.5
.004
Poor 7.7 17.7 5.3 6.1 5.1 17.3 10.7 14.0
Middle 16.4 20.1 16.1 14.2 13.1 20.9 9.0 21.7
Richer 22.7 23.7 30.3 23.4 14.1 18.1 40.9 28.7
Richest 50.6 28.7 48.1 55.7 61.2 26.3 34.4 25.1
No. of living children
0 0.9 0.6
.168
1.6 1.9
.441
1.2 0.5
.463
0.0 0.8
.535
1–2 47.1 45.9 12.2 19.7 33.4 40.5 22.9 29.2
3–4 38.2 34.7 40.9 41.5 42.9 36.3 35.1 31.9
≥5 13.8 18.8 45.3 36.9 22.5 22.7 42.0 38.1
Mean 2.86 3.00 4.28 3.92 3.34 3.24 4.25 3.93
Desire for more children*
Wants in ≤2 years 8.7 5.0
.008
5.5 4.9
<.001
6.6 4.2
.335
4.1 4.0
.256
Wants in >2 years or unsure  
 of timing
22.8 36.5 16.4 46.6 32.2 37.5 26.5 39.6
Undecided/missing 5.3 2.5 8.0 8.2 0.4 1.6 6.6 5.4
Does not want/infecund 63.2 56.0 70.1 40.3 60.8 56.7 62.8 51.0
*Sample size is based on 1,389 weighted cases that were randomly chosen for the long questionnaire. Note: p values from chi-square tests.
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misconceptions and reservations among women, includ-
ing those that increase awareness of the IUD as an emer-
gency contraceptive. They also mentioned that supply-side 
issues could be reduced through training, retraining and 
retention of providers; task shifting; and recruitment of 
enthusiastic, dedicated IUD providers.
DISCUSSION
We can draw several weak or tentative conclusions from 
our analyses. In Sub-Saharan Africa, the availability of the 
implant at health facilities may be greater than that of 
the IUD; users of the IUD are more reliant than users of the 
implant on private supply sources. Compared with IUD 
users, implant users tend to be younger, and more likely to 
start use in the extended postpartum period and be moti-
vated by birthspacing or postponement rather than family 
size limitation. IUD users tend to be more highly educated, 
wealthier and more likely to live in an urban area. Taken 
together, the findings suggest that the IUD may appeal 
to a more privileged group than the implant. Users of 
both methods, however, record high continuation rates, 
although our findings suggest that continuation among 
implant users may be even higher than for IUD users.
In addition, two strong conclusions can be drawn from 
these analyses. First, awareness of the implant has spread 
rapidly and, in many countries, has now surpassed aware-
ness of the IUD. Second, in many countries, the implant’s 
overall level of use and its share of use have both risen 
sharply, whereas the IUD’s overall level of use has remained 
low and its share of use has fallen. The need for LARCs in 
Africa is pressing, and the evidence presented here strongly 
suggests that the implant, not the IUD, is filling the need.
A commonly cited reason for the persistently low levels 
of IUD uptake in Sub-Saharan Africa is the lack of trained 
providers.8,33,34 The remedy appears obvious: to undertake 
more widespread training. However, there are two reasons 
why this strategy is unlikely to succeed on its own. First, 
improving the supply of a product without simultaneously 
increasing demand for it may have little effect. Supply and 
demand are like the two blades of a pair of scissors; one 
without the other is close to useless. In the case of the IUD, 
providers trained in insertion and removal may lose the con-
fidence to use those skills safely if they are not able to put 
them into practice regularly (e.g., several times a month). 
Second, IUD insertion is more complex and takes more 
time than implant insertion, although IUD removal is easier 
than implant removal; this point emerged strongly from 
interviews with key stakeholders. Providers naturally prefer 
the simple procedure to the complex one, and this consid-
eration may be the major reason why implant acceptance 
is rapidly expanding while IUD acceptance is languishing.
The importance of client-related reasons for non-
use of the IUD is difficult to assess. It is certainly more 
intrusive to insert a method into the uterus than to insert 
one into the upper arm, and this is likely to be a major 
barrier, particularly in facilities lacking privacy or female 
staff. Furthermore, the IUD is associated with many 
misconceptions about health risks that may be endorsed 
and sustained over time by potential clients, as well by pro-
viders. The implant is a relatively new method, and thus 
has given rise to fewer misconceptions.
Still, the evidence from interventions that seek to 
increase availability of the IUD or the implant in Africa 
shows that these barriers can be overcome. A PSI initia-
tive in 13 countries—six in Africa—resulted in 576,000 
IUD insertions in 2009–2010.35 Similarly, MSI reported 
167,000 IUD insertions in 20 African countries in 201036 
and 250,000 in 2012.37 Although LARC interventions 
that offer both methods typically result in a ratio of about 
three implant insertions for each IUD insertion, a sizable 
minority of women will chose the IUD when met with 
enthusiastic staff and high-quality counseling.9 Additional 
elements of successful LARC interventions highlighted by 
PSI and MSI include careful coordination of the timing of 
demand-creation activities and service delivery; provision 
of removal services; and activities designed to reach poor 
or underserved women, such as mobile outreach and the 
provision of free or subsidized services. In line with our 
findings on the antecedents to LARC adoption shown 
above, these programs predominantly reached new users. 
Nevertheless, the fact remains that these efforts have not 
prevented the decline of the IUD’s contribution to overall 
contraceptive protection in Sub-Saharan Africa.
Conclusion
This paper raises fundamental questions about the future 
of the IUD in Africa. One position is to take the moral high 
ground and argue that the method must continue to be 
made available in the region because it is imperative that 
women have the widest possible range of choices. Cost 
considerations also favor continued access to the IUD, 
which is considerably cheaper than the implant. If an era 
of diminished U.S. funding for international family plan-
ning is about to start, commodity costs and staff costs 
for counseling, insertion and removal will become more 
important.38 However, a business-as-usual scenario seems 
to be leading nowhere in terms of nationwide success.
We suggest two alternative strategies. The first is a mini-
mal approach that would involve concentrating IUD 
 services in high-volume, urban facilities by training and 
placement of dedicated LARC providers. This strategy 
would be relatively easy to implement and should be cost-
effective; however, it would be limited in terms of coverage 
and national impact.
The second is a maximal approach that would involve 
an expansion of IUD training, a considerable investment 
in IUD demand creation and the provision of some moti-
vating mechanism for providers to offer IUD services 
with enthusiasm. NGOs, such as MSI and PSI, could 
assist, but government commitment would be vital, and 
it is uncertain whether the necessary political will exists. 
Thus far, government family planning agencies in Africa—
except in Kenya—have left IUD services largely to non-
governmental organizations that lack the national reach 
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to implement such a maximal approach, except perhaps 
in small countries. However, as mentioned, the IUD is 
the most cost-effective method, which should appeal to 
governments.
The motivation for providers is the problematic ele-
ment, and perhaps the most crucial one as well. Payments 
for performance could restrict rather than widen choice, 
but to suggest an alternative that would encourage staff to 
spend the time required for IUD counseling and insertion 
without compromising the right of clients to freedom of 
choice is difficult. One interesting possibility is encourag-
ing IUD use among providers themselves—an approach 
that draws on evidence from developed countries that pro-
viders are likely to recommend a method that they have 
used with success.39 We hope that this comment will stim-
ulate discussion of this and other creative ways of improv-
ing the situation.
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Appendix Table 1. Countries included in analysis of IUD and 
implant use in Sub-Saharan Africa, by DHS survey years
Country Survey period 1
(1996–2000)
Survey period 2
(2010–2016)
Benin 1996 2011–2012
Burkina Faso 1998–1999 2010
Cameroon 1998 2011
Chad 1996–1997 2014–2015
Comoros 1996 2012
Cote d’Ivoire 1998–1999 2011–2012
Ethiopia 2000 2011
Gabon 2000 2012
Ghana 1998 2014
Guinea 1999 2012
Kenya 1998 2014
Malawi 2000 2010
Mali 1995–1996 2012–2013
Mozambique 1997 2011
Niger 1998 2012
Rwanda 2000 2014–2015
Senegal 1997 2014
Tanzania 1996 2015–2016
Togo 1998 2013–2014
Uganda 2000–2001 2011
Zambia 1996 2013–2014
Zimbabwe 1999 2015
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